Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
Kallen Schwark, Dana Messinger, Jessica Cummings, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13

Showing 13 citing articles:

Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients
Natalia Stepien, Lisa Mayr, Maria T. Schmook, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 3
Open Access | Times Cited: 11
Chromosomal gain and mutations of platelet-derived growth factor receptor-α gene in canine high-grade oligodendroglioma
K. Yoshida, James Chambers, Kazuyuki Uchida
Veterinary Pathology (2025)
Closed Access
Targeted therapy in pediatric central nervous system tumors: a review from the National Pediatric Cancer Foundation
Benjamin I. Siegel, Prabhumallikarjun Patil, Annapoorna Prakash, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Adult diffuse IDH-wildtype lower-grade gliomas with PDGFRA gain/amplification should be upgraded as glioblastoma
Yue Li, Xiujiao Shen, Ji Zhang, et al.
Journal of Neuropathology & Experimental Neurology (2025)
Closed Access
Gene Therapy for High Grade Glioma: The Clinical Experience
María L. Varela, Andrea Comba, Syed Mohd Faisal, et al.
Expert Opinion on Biological Therapy (2022) Vol. 23, Iss. 2, pp. 145-161
Open Access | Times Cited: 17
The Spectrum of Molecular Pathways in Gliomas—An Up-to-Date Review
Reinhold Nafe, Elke Hattingen
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2281-2281
Open Access | Times Cited: 10
Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients: a single-institution study of 40 patients
Rola H. Ali, Mohamad Almanabri, Noor S Haj Ali, et al.
Journal of Clinical Pathology (2024), pp. jcp-209318
Open Access | Times Cited: 3
Radiotherapy plus temozolomide with or without anlotinib in H3K27M‐mutant diffuse midline glioma: A retrospective cohort study
Chao Liu, Shuwen Kuang, Tianxiang Huang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 3
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy
Marc Zuckermann, Chen He, Jared Andrews, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
New natural compound inhibitors of PDGFRA (platelet-derived growth factor receptor α) based on computational study for high−grade glioma therapy
Wenzhuo Yang, Shengnan Wang, Xiangmao Zhang, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations
Ester Calvo Fernández, Lorenzo Tomassoni, Xu Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pediatric Tumors as Disorders of Development: The Case for In Vitro Modeling Based on Human Stem Cells
Cullen Clairmont, Joanna J. Gell, Ching C. Lau
Cancer Control (2024) Vol. 31
Open Access
Neuropathologie pädiatrischer Hirntumore
B. Reyes Medina, Arne Wrede, Walter Schulz‐Schaeffer
Deleted Journal (2023) Vol. 63, Iss. 8, pp. 577-582
Closed Access
Page 1

Scroll to top